“Although some of this increase is attributable to the 2014 Medicaid expansion, the primary driver was rising DMT costs per prescription, which...
A novel opioid molecule designed to have less abuse potential with slower CNS entry received a unanimous FDA committee turn down.
BALTIMORE – Patients with epilepsy are at higher risk of psychiatric comorbidity than are controls, and the rate of...
Average 8-year follow-up of an international lupus inception cohort showed that 52% developed a neuropsychiatric event.
BALTIMORE – “If you are not convinced to do early treatment,” at least “do surveillance with EEG. You will diagnose epilepsy earlier, and treat...
A neurologist and her colleagues propose changes with the goal of clarifying and harmonizing procedures for determining death by neurologic...
ACHIEVE I and ACHIEVE II demonstrate efficacy.
BALTIMORE – There was a lower risk of intubation with 5 mg midazolam IM or more.
The agency also authorized the first newborn screening test for DMD.